ArticleCase reports in surgery2026
Metastatic Papillary Thyroid Carcinoma Without Intrathyroidal Primary: Case Report and Literature Review.
Article in Case reports in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metastatic Papillary Thyroid Carcinoma Without Intrathyroidal Primary: Case Report and Literature Review.Case reports in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary thyroid carcinoma (PTC) usually has an intrathyroidal primary lesion and a good prognosis. In rare cases, however, individuals may also present with metastatic disease in the absence of a palpable thyroid primary, so-called occult PTC. Such cases are often difficult to diagnose and manage, especially when serial monitoring of serum thyroglobulin (Tg) levels and imaging studies demonstrate the opposite. We report the case of a 56-year-old woman who underwent total thyroidectomy for suspected multinodular goiter in 2019. The results of a histological examination revealed no intrathyroidal tumor in 78 blocks, but one central node was found to be positive for metastatic PTC. Follow-up examination proved that Tg had increased even though the results from U/S, PET/CT, and I-123 WB scans were always negative. Laboratory studies suggested potential heterophile antibody interference, but a fine needle aspiration (FNA) of a cervical node in 2023 and 2024 reported recurrence of metastatic PTC. She underwent left selective lateral neck dissection (levels II-V) with central compartment (level VI) exploration in January 2025, and a number of metastatic nodes without extranodal extension were found. Tg levels were undetectable throughout follow-up with no evidence of residual disease on US postoperatively. The patient remains well on long-term follow-up. We present a rare case of metastatic PTC with no identifiable thyroid primary, which is combined with the diagnostic difficulties of Tg assay interference and limitations of imaging in the follow-up setting. It highlights the importance of multimodal surveillance (including cytology, imaging, and biochemical testing) to ensure true recurrences are accurately detected, often many years after apparently curative surgery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.